{
    "code": "52026887",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026887",
    "time": "2021-07-09 03:53:08",
    "許可證字號": "衛部藥輸字第026887號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/07\/28",
    "發證日期": "105\/07\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202688707",
    "中文品名": "派免敏點眼液0.7%",
    "英文品名": "PAZEO (olopatadine hydrochloride ophthalmic solution) 0.7%",
    "適應症": "適用於治療過敏性結膜炎所引起的眼睛搔癢",
    "劑型": "46A無菌眼用液劑",
    "包裝": "100毫升以下無菌塑膠滴瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "OLOPATADINE HYDROCHLORIDE",
    "限制項目": "02輸　入 26監視期滿新藥",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0011100  ALCON RESEARCH LLC",
            "製造廠廠址": "6201, SOUTH FREEWAY, FORT WORTH, TEXAS 76134, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400006210",
            "成分名稱": "OLOPATADINE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "7.7600000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "026887_PAZEO (olopatadine hydrochloride ophthalmic solution) 0.7%-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026887&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Upload_9017597_TW_p2_LFT_X-4-109-01-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026887&Seq=003&Type=9"
        },
        {
            "title": "9014078_I_PAZEO-106-11-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026887&Seq=002&Type=9"
        },
        {
            "title": "02026887-0002-105-10-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026887&Seq=001&Type=9"
        },
        {
            "title": "Upload_H15639_TW_p1_LBL_X-4-109-01-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026887&Seq=005&Type=8"
        },
        {
            "title": "Upload_9017598_TW_p1_FB_X-4-109-01-07(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026887&Seq=004&Type=8"
        },
        {
            "title": "H14753_L_PAZEO_2.5mL for upload-107-02-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026887&Seq=003&Type=8"
        },
        {
            "title": "9014077_C_PAZEO_2.5mL for upload-107-02-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026887&Seq=002&Type=8"
        },
        {
            "title": "02026887-0001-105-10-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026887&Seq=001&Type=8"
        }
    ]
}